Information Provided By:
Fly News Breaks for November 2, 2018
MDRX
Nov 2, 2018 | 07:32 EDT
Cantor Fitzgerald analyst Steven Halper last night downgraded Allscripts to Neutral from Overweight and lowered his price target for the shares to $12 from $17. The company reported another set of "disappointing" results with revenue and adjusted earnings below expectations, Halper tells investors in a research note. Further, he adds that bookings were weak and Netsmart significantly trailed management's expectations. It is becoming clear the assumption that Allscripts can accelerate growth next year and beyond was too optimistic, says Halper.
News For MDRX From the Last 2 Days
There are no results for your query MDRX